Ding Shengguang, Fan Zhiqing, Lin Che, Dai Qiying, Zhou Jinzhe, Huang Haitao, Xu Yiming, Zhong Chongjun
Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Nantong University, Nantong, 226001, China.
Department of Cardiology, Daqing Qilfield General Hospital, Daqing, 163001, China.
Adv Exp Med Biol. 2017;998:271-281. doi: 10.1007/978-981-10-4397-0_18.
Despite years of researches, cardiovascular disease (CVD) remains the most common cause of death around the world. Lots of studies showed that by pretreating with short nonfatal ischemia in in situ organ or distant organ, one could develop tolerance to the following fatal ischemia. The process is called ischemic preconditioning (IPC). IPC prepare the heart for damage by producing inflammatory signals, miRNA, neuro system stimulation and exosomes. Among them, exosomes have been gaining increasing interest since it is characterized by its capability to carry information and its specific ligand-receptor system. Here we will discuss IPC induced exosomes and its protective effects during ischemic heart disease.
尽管经过多年研究,心血管疾病(CVD)仍是全球最常见的死亡原因。许多研究表明,通过在原位器官或远处器官进行短暂非致死性缺血预处理,可使机体对随后的致死性缺血产生耐受性。这个过程称为缺血预处理(IPC)。IPC通过产生炎症信号、微小RNA、神经系统刺激和外泌体来让心脏为损伤做好准备。其中,外泌体因其携带信息的能力及其特定的配体-受体系统而越来越受到关注。在此,我们将讨论缺血预处理诱导的外泌体及其在缺血性心脏病中的保护作用。